Prepulse inhibition deficit as a transdiagnostic process in neuropsychiatric disorders: a systematic review.
Neuropsychiatric disorders
Pre-attentional filtering
Prepulse inhibition
Sensorimotor gating
Startle response
Transdiagnostic process
Journal
BMC psychology
ISSN: 2050-7283
Titre abrégé: BMC Psychol
Pays: England
ID NLM: 101627676
Informations de publication
Date de publication:
07 Aug 2023
07 Aug 2023
Historique:
received:
07
01
2023
accepted:
18
07
2023
medline:
9
8
2023
pubmed:
8
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
Psychopathological research is moving from a specific approach towards transdiagnosis through the analysis of processes that appear transversally to multiple pathologies. A phenomenon disrupted in several disorders is prepulse inhibition (PPI) of the startle response, in which startle to an intense sensory stimulus, or pulse, is reduced if a weak stimulus, or prepulse, is previously presented. The present systematic review analyzed the role of PPI deficit as a possible transdiagnostic process for four main groups of neuropsychiatric disorders: (1) trauma-, stress-, and anxiety-related disorders (2) mood-related disorders, (3) neurocognitive disorders, and (4) other disorders such as obsessive-compulsive, tic-related, and substance use disorders. We used Web of Science, PubMed and PsycInfo databases to search for experimental case-control articles that were analyzed both qualitatively and based on their potential risk of bias. A total of 64 studies were included in this systematic review. Protocol was submitted prospectively to PROSPERO 04/30/2022 (CRD42022322031). The results showed a general PPI deficit in the diagnostic groups mentioned, with associated deficits in the dopaminergic neurotransmission system, several areas implied such as the medial prefrontal cortex or the amygdala, and related variables such as cognitive deficits and anxiety symptoms. It can be concluded that the PPI deficit appears across most of the neuropsychiatric disorders examined, and it could be considered as a relevant measure in translational research for the early detection of such disorders.
Sections du résumé
BACKGROUND
BACKGROUND
Psychopathological research is moving from a specific approach towards transdiagnosis through the analysis of processes that appear transversally to multiple pathologies. A phenomenon disrupted in several disorders is prepulse inhibition (PPI) of the startle response, in which startle to an intense sensory stimulus, or pulse, is reduced if a weak stimulus, or prepulse, is previously presented.
OBJECTIVE AND METHODS
OBJECTIVE
The present systematic review analyzed the role of PPI deficit as a possible transdiagnostic process for four main groups of neuropsychiatric disorders: (1) trauma-, stress-, and anxiety-related disorders (2) mood-related disorders, (3) neurocognitive disorders, and (4) other disorders such as obsessive-compulsive, tic-related, and substance use disorders. We used Web of Science, PubMed and PsycInfo databases to search for experimental case-control articles that were analyzed both qualitatively and based on their potential risk of bias. A total of 64 studies were included in this systematic review. Protocol was submitted prospectively to PROSPERO 04/30/2022 (CRD42022322031).
RESULTS AND CONCLUSION
CONCLUSIONS
The results showed a general PPI deficit in the diagnostic groups mentioned, with associated deficits in the dopaminergic neurotransmission system, several areas implied such as the medial prefrontal cortex or the amygdala, and related variables such as cognitive deficits and anxiety symptoms. It can be concluded that the PPI deficit appears across most of the neuropsychiatric disorders examined, and it could be considered as a relevant measure in translational research for the early detection of such disorders.
Identifiants
pubmed: 37550772
doi: 10.1186/s40359-023-01253-9
pii: 10.1186/s40359-023-01253-9
pmc: PMC10408198
doi:
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
226Subventions
Organisme : Agencia Estatal de Investigación
ID : PID2019-107530GB-I00
Organisme : Agencia Estatal de Investigación
ID : PID2019-107530GB-I00
Organisme : Ministerio de Universidades (Spain)
ID : FPU21/00344
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Psychopharmacology (Berl). 2001 Jul;156(2-3):234-58
pubmed: 11549226
PLoS One. 2013 May 01;8(5):e62523
pubmed: 23658739
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):317-22
pubmed: 20035817
Rev Neurol. 2004 Feb 16-29;38(4):366-73
pubmed: 14997462
Psychiatry Res. 1996 Oct 16;64(3):169-78
pubmed: 8944395
Neurobiol Learn Mem. 1996 Jul;66(1):67-79
pubmed: 8661252
Neuropsychol Rev. 2005 Dec;15(4):169-83
pubmed: 16395622
Psychophysiology. 1992 Jul;29(4):437-51
pubmed: 1410175
Psychol Med. 2005 Dec;35(12):1737-46
pubmed: 16300689
J Psychopharmacol. 1992 Jan;6(2):176-90
pubmed: 22291349
J Psychiatr Res. 2021 Jul;139:62-70
pubmed: 34044265
Neuropsychopharmacology. 2012 Apr;37(5):1216-23
pubmed: 22218093
J Psychopharmacol. 2016 Nov;30(11):1072-1081
pubmed: 27539931
Psychoneuroendocrinology. 2015 Oct;60:217-23
pubmed: 26189199
Early Interv Psychiatry. 2020 Apr;14(2):196-202
pubmed: 31264797
Behav Brain Res. 2011 Sep 23;222(2):299-308
pubmed: 21458498
Psychiatry Res. 2013 Jan 30;205(1-2):117-26
pubmed: 23017654
Physiol Genomics. 2019 Sep 1;51(9):432-442
pubmed: 31373533
Psychopharmacology (Berl). 1999 Sep;146(2):228-32
pubmed: 10525760
J Psychopharmacol. 2006 Jul;20(4):471-84
pubmed: 16174673
Bipolar Disord. 2005 Apr;7(2):198-203
pubmed: 15762862
Schizophr Res. 2015 May;164(1-3):21-7
pubmed: 25801237
Neurol Sci. 2022 Oct;43(10):5839-5850
pubmed: 35781754
J Vis Exp. 2011 Sep 01;(55):e3446
pubmed: 21912367
World J Biol Psychiatry. 2016 Apr;17(3):187-97
pubmed: 26624257
Synapse. 1991 Sep;9(1):60-5
pubmed: 1796352
Depress Anxiety. 2016 Mar;33(3):238-46
pubmed: 26878422
Neurobiol Aging. 2004 Sep;25(8):1045-50
pubmed: 15212829
Psychopharmacology (Berl). 1999 Mar;142(3):253-60
pubmed: 10208317
Front Behav Neurosci. 2016 Oct 18;10:202
pubmed: 27803654
Biol Psychiatry. 2001 Sep 15;50(6):418-24
pubmed: 11566158
Trends Pharmacol Sci. 1996 Jul;17(7):260-4
pubmed: 8756185
Arch Gen Psychiatry. 1994 Feb;51(2):139-54
pubmed: 8297213
Biomed Res Int. 2015;2015:810548
pubmed: 25918722
Early Interv Psychiatry. 2021 Jun;15(3):652-661
pubmed: 32567764
Clin Neurophysiol. 2003 Jul;114(7):1246-52
pubmed: 12842721
J Acoust Soc Am. 1968 Feb;43(2):269-82
pubmed: 5636789
Am J Psychiatry. 2005 Jan;162(1):43-9
pubmed: 15625200
Neurosci Biobehav Rev. 2009 Sep;33(8):1157-67
pubmed: 19747594
Clin Psychol Rev. 2011 Mar;31(2):225-35
pubmed: 20471738
Psychopharmacology (Berl). 2001 Jul;156(2-3):117-54
pubmed: 11549216
Int J Psychophysiol. 2017 Apr;114:47-54
pubmed: 28189549
J Contextual Behav Sci. 2014 Jul;3(3):155-163
pubmed: 29057212
Psychophysiology. 2010 Sep;47(5):838-45
pubmed: 20233343
Psychophysiology. 2007 Nov;44(6):839-45
pubmed: 17640265
World Psychiatry. 2019 Jun;18(2):192-207
pubmed: 31059629
J Anxiety Disord. 2016 Jan;37:94-103
pubmed: 26745516
Behav Pharmacol. 2002 Feb;13(1):29-37
pubmed: 11990717
Psychopharmacology (Berl). 2008 Aug;199(3):331-88
pubmed: 18568339
J Affect Disord. 2016 May 15;196:87-96
pubmed: 26919057
Percept Mot Skills. 1990 Feb;70(1):235-42
pubmed: 2326123
Depress Anxiety. 2002;15(2):55-60
pubmed: 11891993
Psychopharmacology (Berl). 1978 Jul 6;58(2):137-44
pubmed: 98780
Int J Psychophysiol. 2014 Feb;91(2):73-9
pubmed: 24188916
Ear Hear. 1990 Oct;11(5):340-50
pubmed: 2262083
Psychophysiology. 2015 Mar;52(3):397-406
pubmed: 25234706
Neuroscience. 2010 Jan 20;165(2):601-11
pubmed: 19854244
Neuropsychopharmacology. 2010 Jan;35(1):217-38
pubmed: 19710631
Biol Psychiatry. 1992 Nov 15;32(10):939-43
pubmed: 1467378
Schizophr Bull. 2020 Dec 1;46(6):1482-1497
pubmed: 32506125
J Affect Disord. 2017 Sep;219:209-221
pubmed: 28577505
J Am Acad Child Adolesc Psychiatry. 2005 Aug;44(8):807-14
pubmed: 16034283
Biol Psychiatry. 1996 Jan 1;39(1):33-41
pubmed: 8719124
Syst Rev. 2015 Mar 28;4:36
pubmed: 25875303
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15037-42
pubmed: 21402948
Psychiatry Clin Neurosci. 2006 Feb;60(1):55-62
pubmed: 16472359
J Anxiety Disord. 2010 Jan;24(1):109-13
pubmed: 19819106
Psychopharmacology (Berl). 2003 Jan;165(2):118-27
pubmed: 12417963
Neuropsychopharmacology. 2004 May;29(5):982-90
pubmed: 14970829
Psychopharmacology (Berl). 2006 Jun;186(2):246-54
pubmed: 16583235
J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):106-8
pubmed: 15608006
Psychiatry Res. 2021 Jun;300:113907
pubmed: 33839423
Neuroimage. 2008 Sep 1;42(3):1164-77
pubmed: 18588988
PLoS One. 2012;7(7):e39434
pubmed: 22802938
Biol Psychiatry. 2007 May 15;61(10):1204-7
pubmed: 17161386
Psychol Med. 2019 Mar;49(4):581-589
pubmed: 29769152
Psychopharmacology (Berl). 2001 Jul;156(2-3):194-215
pubmed: 11549223
Psychophysiology. 1975 May;12(3):238-48
pubmed: 1153628
Psychophysiology. 2005 Jan;42(1):1-15
pubmed: 15720576
J Neuroendocrinol. 2009 Mar;21(4):415-20
pubmed: 19187468
Neurotox Res. 2011 Feb;19(2):211-34
pubmed: 20393891
Psychophysiology. 1978 Jul;15(4):339-43
pubmed: 693742
World Psychiatry. 2020 Oct;19(3):311-312
pubmed: 32931117
Am J Psychiatry. 1998 Jun;155(6):812-7
pubmed: 9619155
Res Child Adolesc Psychopathol. 2023 Jul;51(7):1005-1019
pubmed: 37014483
Biol Psychiatry. 2013 Feb 1;73(3):225-34
pubmed: 22959126
World J Biol Psychiatry. 2021 Mar;22(3):183-193
pubmed: 32420779
Neuropsychopharmacology. 2000 Jan;22(1):89-96
pubmed: 10633494
J Affect Disord. 2017 Mar 15;211:75-82
pubmed: 28103521
Curr Alzheimer Res. 2018;15(2):149-156
pubmed: 28847285
Front Pharmacol. 2018 Jul 12;9:758
pubmed: 30050444
Behav Pharmacol. 2005 Sep;16(5-6):447-54
pubmed: 16148450
Biol Psychiatry. 2001 Oct 15;50(8):578-85
pubmed: 11690592
J Psychiatr Res. 2020 Oct;129:272-280
pubmed: 32829082
Biol Psychiatry. 1993 Feb 15;33(4):298-301
pubmed: 8471686
Front Psychol. 2016 Feb 19;7:206
pubmed: 26925020
J Psychopharmacol. 2015 Oct;29(10):1070-6
pubmed: 26253620
J Affect Disord. 2010 Oct;126(1-2):188-97
pubmed: 20347156
Biol Psychiatry. 1997 May 15;41(10):1035-44
pubmed: 9129784
J Consult Clin Psychol. 2020 Mar;88(3):179-195
pubmed: 32068421
JAMA Psychiatry. 2019 Nov 1;76(11):1176-1186
pubmed: 31461131
Int J Psychophysiol. 2015 Nov;98(2 Pt 2):321-329
pubmed: 25816797
J Int Neuropsychol Soc. 2012 Jul;18(4):643-56
pubmed: 22613272
Neurosci Biobehav Rev. 2013 Jul;37(6):1150-6
pubmed: 23017868
Bipolar Disord. 2007 May;9(3):221-9
pubmed: 17430296
Behav Ther. 2007 Sep;38(3):284-302
pubmed: 17697853
Clin Psychopharmacol Neurosci. 2011 Dec;9(3):102-10
pubmed: 23429840
Schizophr Bull. 1987;13(4):643-68
pubmed: 3438708
Psychiatry Res. 2006 Aug 30;143(2-3):147-58
pubmed: 16879870
BMC Psychiatry. 2021 Apr 23;21(1):209
pubmed: 33892659
J Affect Disord. 2004 Aug;81(2):179-84
pubmed: 15306146
Psychopharmacology (Berl). 2004 May;173(3-4):418-24
pubmed: 14722707
Transl Psychiatry. 2015 Nov 10;5:e675
pubmed: 26556284
Rev Neurol. 2017 Dec 1;65(11):507-519
pubmed: 29178109
Arch Gen Psychiatry. 1990 Feb;47(2):181-8
pubmed: 2405807
Brain Res. 1994 Oct 24;661(1-2):174-80
pubmed: 7834367
Clin Psychol Rev. 2019 Aug;72:101751
pubmed: 31271848
Parkinsonism Relat Disord. 2014 Mar;20(3):297-302
pubmed: 24355363
Drug Alcohol Depend. 2011 Jul 1;116(1-3):110-6
pubmed: 21196088
Neuropsychopharmacology. 2014 May;39(6):1479-89
pubmed: 24385130
Behav Brain Res. 2020 Jan 27;378:112251
pubmed: 31614188
Physiol Behav. 2016 Oct 15;165:179-86
pubmed: 27484698
Psychophysiology. 2012 Apr;49(4):484-8
pubmed: 22176532
Biol Psychiatry. 2005 May 15;57(10):1153-8
pubmed: 15866555
Rev Neurol. 2011 Oct 1;53(7):422-32
pubmed: 21948013
Int J Neuropsychopharmacol. 2008 Nov;11(7):947-55
pubmed: 18477413
Am J Psychiatry. 2014 Apr;171(4):395-7
pubmed: 24687194
Soc Psychiatry Psychiatr Epidemiol. 2017 Jan;52(1):1-10
pubmed: 27921134
J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):192-200
pubmed: 7876851
Psychiatry Res. 2018 Apr;262:413-419
pubmed: 28918862
J Psychiatry Neurosci. 2005 Jan;30(1):37-43
pubmed: 15644996
Neurotox Res. 2006 Dec;10(3-4):211-20
pubmed: 17197371
Int Clin Psychopharmacol. 2010 Jul;25(4):232-40
pubmed: 20568657
J Child Psychol Psychiatry. 2014 Aug;55(8):849-51
pubmed: 25039570
Acta Psychiatr Scand. 2016 Oct;134(4):350-9
pubmed: 27294331
Int J Psychophysiol. 2007 May;64(2):157-64
pubmed: 17350126
Psychiatry Res. 2013 Oct 30;214(1):33-41
pubmed: 23916249
J Affect Disord. 2018 Nov;240:63-71
pubmed: 30056171
J Neuropsychiatry Clin Neurosci. 2015 Winter;27(1):48-53
pubmed: 25716487
Behav Brain Res. 2009 Feb 11;197(2):251-61
pubmed: 18801390
J Psychiatr Res. 2013 Apr;47(4):445-52
pubmed: 23287742
Neuropsychopharmacology. 2009 Jun;34(7):1854-64
pubmed: 19242406
Eur J Pharmacol. 2007 Apr 10;560(2-3):176-82
pubmed: 17328888
J Clin Neurophysiol. 2019 Nov;36(6):452-459
pubmed: 31688329
Int J Surg. 2021 Apr;88:105906
pubmed: 33789826
Schizophr Res. 2018 Aug;198:1-5
pubmed: 29525460
Int J Neurosci. 1996 Feb;84(1-4):15-33
pubmed: 8707477
Neuropsychopharmacology. 2016 Dec;41(13):2963-2964
pubmed: 27818517
Schizophr Res. 2020 Feb;216:357-366
pubmed: 31796306
Curr Top Behav Neurosci. 2012;12:251-318
pubmed: 22367921
Expert Rev Neurother. 2014 May;14(5):569-81
pubmed: 24738763
Schizophr Bull. 2014 May;40(3):642-52
pubmed: 23599252
Biol Psychiatry. 2007 Dec 15;62(12):1418-22
pubmed: 17481589
Am J Psychiatry. 1993 Dec;150(12):1862-7
pubmed: 8238643
Neuron. 2012 Jun 21;74(6):990-1004
pubmed: 22726830
Exp Neurol. 2016 Sep;283(Pt A):142-50
pubmed: 27302677
Brain Sci. 2022 Jan 11;12(1):
pubmed: 35053836
Neuropsychopharmacology. 2022 Dec;47(13):2238-2244
pubmed: 36192631
Emotion. 2012 Dec;12(6):1264-72
pubmed: 22775129
Brain Sci. 2021 Feb 20;11(2):
pubmed: 33672693
Int J Neuropsychopharmacol. 2009 Oct;12(9):1249-59
pubmed: 19490735
Front Psychiatry. 2018 Apr 18;9:123
pubmed: 29720950
J Affect Disord. 2006 Jun;92(2-3):299-303
pubmed: 16503358
Stereotact Funct Neurosurg. 2015;93(4):265-70
pubmed: 26066569
Prog Neurobiol. 2020 Feb;185:101734
pubmed: 31863802
J Abnorm Psychol. 2010 Nov;119(4):631-9
pubmed: 20939653
J Dual Diagn. 2021 Oct-Dec;17(4):277-283
pubmed: 34392807
Biol Psychiatry. 1998 Nov 15;44(10):1027-36
pubmed: 9821567
Psychophysiology. 2016 Sep;53(9):1377-85
pubmed: 27237725
Eur Neuropsychopharmacol. 2016 Apr;26(4):767-76
pubmed: 26857197
Psychopharmacology (Berl). 2013 Dec;230(3):477-85
pubmed: 23828156
Biol Psychol. 2006 Feb;71(2):123-47
pubmed: 15961210
J Anxiety Disord. 2016 Apr;39:30-43
pubmed: 26945765
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):925-32
pubmed: 9204670
Neuroreport. 2009 Feb 18;20(3):331-6
pubmed: 19444955
Neuropharmacology. 2014 Jan;76 Pt B:370-82
pubmed: 23747571
Clin Psychol Rev. 2015 Aug;40:91-110
pubmed: 26094079
Rev Neurol. 2021 Feb 16;72(4):121-132
pubmed: 33570159